Hepion Pharmaceuticals, Inc.
HEPA
$0.04
-$0.02-27.83%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.03% | 54.68% | 82.92% | -294.57% | 68.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 67.34% |
| Total Other Non-Cash Items | 173.15% | 83.98% | -106.12% | 1,185.88% | -1,059.27% |
| Change in Net Operating Assets | 292.28% | 296.80% | -122.43% | 277.43% | -97.68% |
| Cash from Operations | 25.38% | 67.57% | -23.09% | 3.08% | 54.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | 100.00% |
| Cash from Investing | -- | 100.00% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.78% | -1.88% | 94.67% | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -1.78% | -1.88% | -102.92% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.28% | 63.70% | -139.76% | 483.24% | -76.52% |